Medical Research News

RSS

Grape-enriched diet prevents risk factors for metabolic syndrome: Researchers

Scientists at the University of Michigan Health System are teasing out clues to the effect of grapes in reducing risk factors related to cardiovascular disease and metabolic syndrome. The effect is thought to be due to phytochemicals -- naturally occurring antioxidants - that grapes contain.

26 Apr 2010

Life Technologies debuts Invitrogen MAGic Sample Processor for addressing reproducibility challenges

Life Technologies Corporation today debuted the life science industry's first benchtop sample preparation system designed to increase productivity while eliminating manual and contamination-related challenges traditionally associated with protein and epigenetic protocols. The Invitrogen MAGic™ Sample Processor enables researchers to cut protocol time in half, dramatically reduce experimental errors, and perform technically challenging experiments in protein purification and epigenetics.

26 Apr 2010

Researchers synthesize metal compounds that can be effective in treatment of cancer

Scientists from Bochum have managed to accurately determine the location of metal complexes within living cancer cells using Raman microscopy. The researchers have thus gained new insights into the mechanism of action of metal-containing drugs, to which they ascribe great potential capacities, e.g. in the treatment of cancer.

26 Apr 2010

Long telomeres in non-demented adults and seniors associated with poorer memory: Researchers

A team of collaborating researchers from the Swedish universities of Umeå, Stockholm, and Linköping is now publishing data showing that long telomeres in non-demented adults and seniors can be associated with poorer memory.

26 Apr 2010

Odors classified into groups by discrete activity states of neuronal circuits: Scientists

Scientists at the Friedrich Miescher Institute for Biomedical Research (FMI, part of the Novartis Research Foundation), are unraveling how odors are processed by the brain. As they report in Nature, odors in the olfactory brain are classified into groups represented by discrete activity states of neuronal circuits.

26 Apr 2010

U.S. DOE awards Verenium additional $4.9M for development of cellulosic ethanol biorefinery plants

Verenium Corporation, a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, today announced that it has been awarded an additional $4.9 million from the U.S. Department of Energy (DOE) to fund ongoing activities at its demonstration-scale facility in Jennings, Louisiana.

26 Apr 2010

Anacor Pharmaceuticals, MMV partner to discover and develop promising new malaria therapeutics

Anacor Pharmaceuticals today announced that it has entered into a research agreement with not-for-profit Medicines for Malaria Venture (MMV) to explore Anacor's novel boron chemistry platform for developing new therapeutics for the treatment of malaria. Under the agreement, Anacor will be responsible for leading the research effort and MMV will contribute its extensive malaria drug research expertise as well as financial support.

26 Apr 2010

Promising research on cryptosporidiosis could lead to effective treatment: Brandeis University biochemist

Discovered in 1976, cryptosporidium lurks worldwide in water, contaminating swimming pools, water parks, and drinking water supplies. Although it has even been featured on the comedy show The Colbert Report, it is no laughing matter-this microscopic pathogen is a leading cause of diarrhea and malnutrition and the most common source of infection in immune-weakened people such as AIDS patients.

26 Apr 2010

Middle-school children restricted to R-rated movies less likely to start drinking: Study

Middle-school children whose parents restrict access to R-rated movies are substantially less likely to start drinking than their peers who are allowed to see such films, a new study suggests.

26 Apr 2010

Cedars-Sinai Heart Institute presents new findings on heart transplantation rejection factors

Physician scientists at the Cedars-Sinai Heart Institute are presenting new findings on heart transplantation rejection factors such as race and gender, the effects of pre-transplant smoking and whether homeless organ donors put recipients at higher risk for complications. The presentations will take place April 21 - 24 in Chicago during the 30th Annual Scientific Meeting of the International Society of Heart and Lung Transplantation.

26 Apr 2010

Charles River Laboratories International, WuXi PharmaTech sign definitive agreement to combine

Charles River Laboratories International, Inc., a leading global provider of research models and associated services and of preclinical drug development services, and WuXi PharmaTech, a leading drug research and development outsourcing company with expertise in discovery chemistry and with operations in China and the United States, today announced that they have signed a definitive agreement under which Charles River and WuXi will combine in a cash and stock transaction valued at approximately $1.6 billion.

26 Apr 2010

Serum cortisol levels linked with increased mortality in patients with ACS: Research

Growing evidence suggests that serum cortisol levels are associated with increased cardiovascular mortality in patients with chronic heart failure, research presented at this week's European Congress of Endocrinology shows.

26 Apr 2010

Genes that predispose to smoking behavior and lung cancer identified: More reason to quit say researchers

According to new research there are certain genes in a smoker that make it difficult for them to cut down or quit the bad habit. This report from three studies published in the journal Nature Genetics mentions at least three different genetic mutations on chromosome 15 or changes that can increase the number of cigarettes smoked per day by an individual.

25 Apr 2010

World’s largest study on the safety of using mobile phones

Health experts have been saying that mobile phones are bad for us for a long time. Now they are getting set to prove it beyond any doubt. Researchers in London recently launched the world’s largest study on the safety of using mobile phones. A quarter of a million mobile phone users will be tracked through their medical records for more than 20 years. This is the largest study in the world on the health effects of using mobile phones and is being called Cosmos.

25 Apr 2010

Personal risk of developing prostate cancer increases when more direct relatives are affected

For a long time now doctors have known that prostate cancer "runs in the family". Men with family members who have been diagnosed with the disease have an elevated risk of developing cancer of the prostate. But exactly how high is an individual person's risk? For whom and at what age should an early detection screening urgently be recommended?

24 Apr 2010

Highlights from AACE 19th Annual Meeting and Clinical Congress

today's highlights from the AACE Annual Meeting & Clinical Congress in Boston

24 Apr 2010

Psychological acupuncture successful in reducing food cravings in obese people: Study

Psychological acupuncture has been shown to be successful in reducing food cravings for up to six months in people who are overweight or obese.

24 Apr 2010

Overweight adolescent children tend to follow weight-control strategies of their parents: Study

When parents maintain a healthy body image and weight-control strategies, overweight adolescent children tend to follow their example, a new study reveals.

24 Apr 2010

19.6% of completed stroke trials not published in full

An investigation into unpublished stroke research data has revealed that 19.6% of completed clinical trials, which could potentially influence patient care, are not published in full. Researchers writing in BioMed Central's open access journal Trials describe how these unpublished studies included more than 16,000 participants and tested 89 different interventions.

24 Apr 2010

Presidio Pharmaceuticals, Numerate conclude collaboration to discover new compounds targeting HCV

Presidio Pharmaceuticals, Inc., and Numerate, Inc., today announced that they have concluded their two-year collaboration to discover new compounds that target hepatitis C virus (HCV).

24 Apr 2010

Medical Research News

Grape-enriched diet prevents risk factors for metabolic syndrome: Researchers

Life Technologies debuts Invitrogen MAGic Sample Processor for addressing reproducibility challenges

Researchers synthesize metal compounds that can be effective in treatment of cancer

Long telomeres in non-demented adults and seniors associated with poorer memory: Researchers

Odors classified into groups by discrete activity states of neuronal circuits: Scientists

U.S. DOE awards Verenium additional $4.9M for development of cellulosic ethanol biorefinery plants

Anacor Pharmaceuticals, MMV partner to discover and develop promising new malaria therapeutics

Promising research on cryptosporidiosis could lead to effective treatment: Brandeis University biochemist

Middle-school children restricted to R-rated movies less likely to start drinking: Study

Cedars-Sinai Heart Institute presents new findings on heart transplantation rejection factors

Charles River Laboratories International, WuXi PharmaTech sign definitive agreement to combine

Serum cortisol levels linked with increased mortality in patients with ACS: Research

Genes that predispose to smoking behavior and lung cancer identified: More reason to quit say researchers

World’s largest study on the safety of using mobile phones

Personal risk of developing prostate cancer increases when more direct relatives are affected

Highlights from AACE 19th Annual Meeting and Clinical Congress

Psychological acupuncture successful in reducing food cravings in obese people: Study

Overweight adolescent children tend to follow weight-control strategies of their parents: Study

19.6% of completed stroke trials not published in full

Presidio Pharmaceuticals, Numerate conclude collaboration to discover new compounds targeting HCV

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Latest News